Key Investors Highlights

My-Cardia (USA) Inc.

My-Cardia (USA) Inc. is a wholly owned subsidiary of CB Scientific, Inc. The subsidiary supplies devices, software, smartphone apps, IT support, and technical and clinical services to our international distributors and partners.

Conducting NMPA Trials

CB Scientific, Inc. has been conducting device trial seminars across China to raise awareness of its MyCardia AT device. These trials are part of our efforts to expand into the Chinese market.

US FDA 510K Registration

CB Scientific, Inc. has clearance to market US FDA 510K Registration for our products through My-Cardia (USA) Inc. The MyCardia AT device is also in the pre-registration phase with the National Medical Product Administration (NMPA) in China.

Global Expansion

Our products are available through authorized distributors in Thailand, Malaysia, Singapore, Indonesia, Hong Kong, Macau, and Canada, further broadening our global reach in cardiac monitoring technology.

Want to get in touch with our team? We are available.

Get our news in your inbox!

Join our newsletter and we will send our news directly to you.